Siva Krishna Nangedda

Title: Siva Krishna Nangedda: Innovator in Pharmaceutical Chemistry

Introduction

Siva Krishna Nangedda is a notable inventor based in Mandavalli, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative treatments for multiple sclerosis. His work exemplifies the intersection of scientific research and practical application in medicine.

Latest Patents

Nangedda holds a patent titled "Methods for the preparation of sphingosine 1-phosphate receptor modulators and solid forms thereof." This invention relates to a process for preparing a specific compound, 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxy imino]ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid, along with its intermediates, salts, and solid forms. The pharmaceutical compositions derived from this patent are intended for the treatment of multiple sclerosis, particularly secondary progressive multiple sclerosis. He has 1 patent to his name.

Career Highlights

Siva Krishna Nangedda is currently associated with Cipla Limited, a leading global pharmaceutical company. His role involves extensive research and development aimed at creating effective therapeutic solutions. His dedication to advancing medical science is evident in his innovative approaches to drug formulation.

Collaborations

Nangedda has collaborated with esteemed colleagues, including Srinivas Laxminarayan Pathi and Puppala Ravi Kumar. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Siva Krishna Nangedda's contributions to pharmaceutical chemistry highlight his commitment to improving healthcare through innovation. His patent work and collaborations reflect a dedication to addressing complex medical challenges.